Citrullinemia type II

Get in touch with RARE Concierge.

Contact RARE Concierge

Citrullinemia type II

Synonyms: Adult-onset citrin deficiency | Adult-onset citrullinemia type 2 | Adult-onset citrullinemia type II | CTLN2 | Citrullinemia type 2

A severe subtype of citrin deficiency characterized clinically by adult onset (20 and 50 years of age) recurrent episodes of hyperammonemia and associated neuropsychiatric symptoms such as nocturnal delirium confusion restlessness disorientation drowsiness memory loss abnormal behavior (aggression irritability and hyperactivity) seizures and coma.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Citrullinemia type II?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Citrin Foundation

Citrin Foundation is a research-driven, non-profit organization set up to tackle citrin deficiency. Our goal is to ultimately find effective treatments and a cure for the condition. We fund research projects to better understand the condition and develop new therapies. We also provide support to citrin deficiency patients and their families globally.

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

flok Health (formerly National PKU News)

National PKU News provides resources and support for individuals, families, and clinicians managing PKU (Phenylketonuria) and other inborn errors of metabolism. Our mission is to leverage innovation, insight, and research to improve the health, well-being, and daily lives of those with PKU and other IEMs.

Clinical Trials

For a list of clinical trials in this disease area, please click here.